The purpose is to investigate the effect of oral doses of SLx-4090 over 14 days on subjects with high triglycerides.
1. Serum triglycerides 2. Serum lipids and lipoproteins 3. Safety and tolerability
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
24
FOCUS Clinical Drug Development GmbH
Neuss, Germany
Serum triglycerides
Time frame: 14 days
Adverse events and vital signs
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.